Federal Agency · Food and Drug Administration
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Last updated: November 6, 2026
Posted July 11, 2025
- Who can apply
- See eligibility below
- Amount
- Up to $900K
- Deadline
- May 16, 2028 · 556 days remaining
- Where
- Nationwide
- Status
- Open
The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.
Program Details
Food and Drug Administration is a federal agency that offers the Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required) grant program to support eligible programs and projects. This funding opportunity is available nationally and is administered by Food and Drug Administration through Grants.gov. Organizations seeking funding for eligible programs and projects should review the details below and confirm their eligibility before preparing an application.
Eligibility
Eligible applicants include eligible organizations. Organizations that meet the eligibility criteria are encouraged to apply and to review the full program guidelines before submission. Because eligibility rules and funding priorities can change between cycles, applicants should always confirm the current requirements with Food and Drug Administration or on Grants.gov before investing time in an application.
Funding and Timeline
Funding available: up to $900K. The application deadline is May 16, 2028 (556 days remaining). Applicants should allow sufficient time to gather required documentation, including organizational information, project descriptions, budgets, and supporting materials as specified in the program guidelines. Submitting a complete application well ahead of the deadline reduces the risk of disqualification on technical or administrative grounds.
Program Focus
This grant supports eligible programs and projects. This grant is associated with NAICS industry classifications: 541714, 325412. Organizations operating in these sectors are encouraged to review eligibility. Funded projects are expected to demonstrate measurable outcomes aligned with the program's stated objectives. Grant recipients may be required to submit progress reports and final evaluations as a condition of the award, and to retain records for audit and compliance purposes.
How to Apply
Eligible organizations can apply through Grants.gov. Create a free organization profile on GrantRegister to see whether this grant matches your organization's NAICS code, entity type, location, and focus area, and to receive a weekly digest of every open grant you qualify for. GrantRegister maintains a complete, authoritative registry of US federal, state, and foundation grant opportunities — matched automatically to your organization profile and delivered every Monday.
Focus area
- Funded by FDA
NAICS: 541714, 325412
Award details
Awards of up to $900K. Applications close on May 16, 2028 (556 days remaining).
Categories
Not categorized
Grants.gov ↗·Last verified November 6, 2026
Similar grants
- Balanced Prosecution of Transnational Organized Crime CasesBureau of International Narcotics-Law Enforcement · closes November 9, 2026
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)National Institutes of Health · closes November 9, 2026
- Fiscal Year (FY) 2026 Funding Opportunity for Indian Tribes and Intertribal Consortia for Nonpoint Source Management Grants Under Clean Water Act Section 319Environmental Protection Agency · closes November 9, 2026
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)National Institutes of Health · closes November 9, 2026
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)National Institutes of Health · closes November 10, 2026
- ROSES25: C.4 Planetary Science Enabling FacilitiesNASA Headquarters · closes November 10, 2026
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)National Institutes of Health · closes November 10, 2026
- BJA FY26 Paul Coverdell Forensic Science Improvement - Formula Grants ProgramBureau of Justice Assistance · closes November 10, 2026
